MedPath

The effect of intravenous Hyoscine-N-butylbromide on active phase labor pain in primigravid wome

Not Applicable
Conditions
abor pain.
Spontaneous vertex delivery
Registration Number
IRCT2015080423444N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
105
Inclusion Criteria

Term pregnancy (37-42 weeks), pregnancy with a single live fetus, cephalic presentation, intact membrance, enter in the active phase of labor( cervical dilatation of 4 cm) with uterine contraction (at least 3 contraction lasting 40-60 seconds in 10 minutes), estimated fetal weight between 2500-4500 gr and absence of contraindication for vaginal delivery were the criteria for inclusion. The women with chronic induced illnesses, severe prepartum hemorrhage, preeclampsia, emergency cesarean section, prior uterine scar and the need to use other methods of analgesia (epidural analgesia or other opioids) were evicted from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
abor pain. Timepoint: before injection and at times of 10, 20, 30, 60 and 120 minutes after injection. Method of measurement: Visual analogue scale.
Secondary Outcome Measures
NameTimeMethod
enght of active phase. Timepoint: durind of first stage of labor. Method of measurement: examination.;Duration of second stage of labor. Timepoint: During second stage of labor. Method of measurement: examination.;Duration of third stage of labor. Timepoint: During third stage of labor. Method of measurement: examination.;Apgar score. Timepoint: at 1st and 5th minutes. Method of measurement: examination.
© Copyright 2025. All Rights Reserved by MedPath